Autres langues 9 Meters Biopharma, Inc.

Actions

Marché Fermé - OTC Markets Autres places de cotation 15:30:05 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00%		0,00%	0,00%

2023	Illumina réduit ses prévisions de bénéfices annuels en raison de la persistance des problèmes de financement dans le secteur de la biotechnologie	RE
2023	Illumina réduit ses prévisions de bénéfices annuels	RE

North American Morning Briefing : Tech in Focus on -2-	25/03
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11
North American Morning Briefing : Stocks Look to -2-	06/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11
Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	02/10/23
North American Morning Briefing : Stock Futures -2-	22/09/23
North American Morning Briefing : Mood Seen Buoyed -2-	15/09/23
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08/09/23
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01/09/23
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25/08/23
North American Morning Briefing : China Trouble Hits Sentiment	18/08/23
North American Morning Briefing : Stock Futures -2-	11/08/23
Illumina cuts annual profit forecast as biotech funding woes linger	09/08/23
Illumina cuts annual profit forecast	09/08/23
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25/07/23
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21/07/23
Drug developer 9 Meters Biopharma files for bankruptcy protection	18/07/23
9 Meters Biopharma, Inc. Filed for Bankruptcy	17/07/23

Aucun résultat pour cette recherche